humanitarian Archived signal

Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Ablymico, liraglutide, Date of authorisation: 15/07/2026, Revision: 1, Status: Authorised

Reported by EMA What Is New Nov 6, 2026 · 15:10 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 34, Status: Authorised15:10 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 34, Status: Authorised15:10 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Lacosamide Accord, lacosamide, Date of authorisation: 18/09/2017, Revision: 14, Status: Authorised14:58 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Lacosamide Accord, lacosamide, Date of authorisation: 18/09/2017, Revision: 14, Status: Authorised14:58 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 26, Status: Authorised14:16 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 26, Status: Authorised14:16 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation: 19/11/2015, Revision: 28, Status: Authorised14:06 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation: 19/11/2015, Revision: 28, Status: Authorised14:06 UTC EMA What Is NewVeterinary medicines European public assessment report (EPAR): Scovella, velagliflozin, Status: Opinion13:20 UTC EMA What Is NewVeterinary medicines European public assessment report (EPAR): Credelio Quattro, lotilaner,moxidectin,pyrantel,praziquantel, Status: Opinion13:20 UTC EMA What Is NewVeterinary medicines European public assessment report (EPAR): Laverdia, verdinexor, Status: Opinion13:20 UTC EMA What Is NewVeterinary medicines European public assessment report (EPAR): Scovella, velagliflozin, Status: Opinion13:20 UTC

INCIDENT EVOLUTION

3 recorded states

Nov 6 · 15:25 UTC

Signal first indexedP2 · 99% quality · 2 sources

Nov 6 · 15:26 UTC

Headline updatedP2 · 99% quality · 2 sources

Nov 6 · 15:50 UTC

Source details updatedP2 · 99% quality · 2 sources

Explore this day in the archive →